Research > ETFs > ETF / ETP Commentary > 

1-Month Fluke? China's July Surprise

July was riddled with small reversals brewing beneath the surface of the market’s quiet headline returns. Capital pivoted from growth into value, large caps into small caps, and the newer digital economy into the real economy — as evidenced by strength in financials, healthcare, and real estate. However, the most eye-catching reversal was the dramatic shift away from high-flying international markets toward China ETFs.Key Takeaways Capital fled AI-heavy markets as Hong Kong’s Hang Seng surged 13%, dwarfing global peers. CXMT’s massive 466% debut surge highlighted accelerating investor momentum across China’s domestic AI and chip stack. Offshore tech and consumer ETFs like MAGC (22%), CHIQ (18%), and KWEB (16%) rallied, while onshore A-shares fell. Hong Kong-listed Chinese equities were the best-performing major country market globally. The Hang Seng Index gained roughly 13% for the month, dwarfing every other market on the board. Meanwhile, Japan’s Nikkei saw its first down month in four months and South Korea’s Kospi put on its worst monthly showing on record — plunging roughly 30% or more.Rising Chip & AI AutonomyThis dynamic was driven primarily by rotation rather than revolution. Many markets that had led earlier in the year — especially AI-heavy hot spots like the U.S., Taiwan, and South Korea — experienced profit-taking as investors questioned lofty semiconductor and AI valuations. Consequently, China’s deeply discounted technology sector began to look attractive on a relative basis. Chip-heavy indexes in South Korea and Japan had ridden an AI memory boom to spectacular first-half gains but cracked late last month on concerns that AI capital expenditure was outpacing short-term returns. Compounding this, reports surfaced that China is rapidly closing the semiconductor gap. ChangXin Memory Technologies (CXMT) surged 466% on its Shanghai debut, temporarily becoming China’s most valuable company and shaking up confidence in Korea’s memory monopoly. Moonshot AI, maker of the Kimi chatbot, closed a $3.5 billion round at a $35 billion valuation — up from $10 billion earlier this year. All this momentum bolstered the narrative that China’s broader AI stack is becoming investable again.China ETFs: Driving the Offshore ReboundRotational flows out of global tech hardware into offshore internet giants and platform plays sparked a sharp tactical rally in Hong Kong-listed consumer and technology vehicles. A look under the hood reveals how different portfolio compositions drove July’s performance across popular China ETFs. Investors looking to target China’s heavyweights saw the strongest upside in mega-cap tech strategies. Leading overall performance, the Roundhill China Magnificent Seven ETF (MAGC) soared 22% in July as investors reallocated capital directly out of Western tech hardware. MAGC concentrates its portfolio into China’s premier tech giants — including Tencent (TCEHY), Alibaba (BABA), and Baidu (BIDU) — offering concentrated exposure to the country’s core AI and cloud leaders. Meanwhile, the KraneShares CSI China Internet ETF (KWEB B) rose 16%. Heavily weighted toward offshore internet and e-commerce giants, KWEB serves as a core vehicle for capturing the sharp rebound in platform companies. Beyond pure tech, tactical flows extended into consumer services and broad blue-chip exposures. The Global X MSCI China Consumer Discretionary ETF (CHIQ B-) posted an 18% gain in July. CHIQ tilts heavily toward digital retail and consumer platforms — with top holdings like Meituan (3690:HKG), Alibaba, and BYD (BYDDY) — benefiting directly from tactical rotation into China’s service economy. For investors seeking diversified blue-chip exposure, the iShares China Large-Cap ETF (FXI A) rose 16% on a NAV basis. Unlike KWEB’s pureplay tech focus, FXI balances its top internet holdings with substantial allocations to state-owned financial institutions like China Construction Bank and ICBC, offering broader large-cap liquidity on the Hong Kong Stock Exchange.Two Key CaveatsTwo significant caveats temper the “China won July” narrative… First, China is not a monolith: While Hong Kong-listed tech and AI stocks powered July’s rally, broad mainland A-shares lagged, as evidenced by a roughly 6% drop in the Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR B+). Yet despite the pullback, ASHR remains up roughly 10% year to date, reflecting strength in domestically oriented sectors such as financials, consumer, industrials, and batteries. In many ways, this pattern is not unlike what has unfolded in the U.S., where market leadership has broadened beyond the “Mag 7” to include value stocks, small- and mid-caps industrials, and other cyclical sectors. Second, China has been a chronic underperformer for most of the past five years due to regulatory crackdowns, a property market crisis, and lingering deflationary pressures. Fund flows have not yet matched price action. China continues to register net outflows, while South Korea remains the primary destination for single-region ETF inflows.Bulls vs. BearsChina bulls would argue valuations remain well below most major markets, AI and cloud investment is accelerating, and additional policy easing remains possible. Not to mention, foreign investors are still underweight China. Meanwhile, bears would point to weak consumer demand and the property sector as structural headwinds — along with export restrictions and regulatory uncertainty. Economic growth is also expected to remain moderate for the foreseeable future. Geopolitical risk remains the primary overhang. U.S. export controls on advanced chips, a China-US trade truce set to expire in November, and Taiwan Strait tensions could shift market sentiment quickly. While July’s market leadership was distinct, long-term investors should remain cautious before extrapolating a single month’s tactical rotation into a structural supercycle. For more news, information, and strategy, visit ETFdb.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.